Is EFX or MEDP cheaper?

On trailing earnings, EFX is cheaper: EFX trades at a 24.97 P/E and MEDP at 35.23.

Which has grown faster, EFX or MEDP?

Over the past five years, MEDP grew revenue faster — EFX at a 6.82% CAGR versus MEDP at 22.03%.

Does EFX or MEDP pay a bigger dividend?

EFX pays a dividend (1.23% yield) while MEDP does not currently pay one.

Is EFX or MEDP more profitable?

MEDP runs the higher net margin — EFX at 10.73% versus MEDP at 17.67%.

Which has been the better investment, EFX or MEDP?

Over the past 5-year, MEDP delivered the higher annualized total return — EFX at 3.40% versus MEDP at 26.97%. Past performance doesn't predict future results.

Equifax Inc. (EFX) vs Medpace Holdings, Inc. (MEDP)

MEDP leads on 9 of 16 compared metrics, though EFX is the cheaper stock.

A side-by-side comparison of Equifax Inc. and Medpace Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 24, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

EFX

Equifax Inc.

$20.27B

$172.54IndustrialsDelayed quote: Jul 24, 2026, 4:00 PM EDT

MEDP

Medpace Holdings, Inc.

$17.18B

$601.38HealthcareAt close: Jul 24, 2026, 4:00 PM ET

Total return — EFX vs MEDP

growth of $100 · dividends reinvested · last 10y

EFX +43.3%MEDP +2064.0%MEDP compounded faster

Log scale — wide-divergence pair

EFX MEDP

EFX vs MEDP: by the numbers

•EFX is the larger company ($20.27B vs $17.18B market cap).
•EFX trades at the lower earnings multiple (24.97 vs 35.23 P/E).
•MEDP converts more revenue to profit (17.67% vs 10.73% net margin).
•MEDP grew revenue faster over the past five years (22.03% vs 6.82% CAGR).
•EFX pays a dividend (1.23% yield) while MEDP does not currently pay one.

Which is better, EFX or MEDP?

Metric tally: EFX 7 · MEDP 9

It depends on what you're optimizing for:

ValueEFX(lower P/E)

GrowthMEDP(faster 5Y revenue CAGR)

QualityMEDP(higher ROIC)

Metrics side by side

Valuation

Metric	EFX	MEDP
P/E ratio	24.97●	35.23
Forward P/E	20.14●	34.28
P/S ratio	3.19●	6.22
P/B ratio	4.70●	39.87
PEG ratio	4.12	1.82●
EV / EBITDA	13.71●	28.30
FCF yield	5.37%●	4.42%

Profitability

Metric	EFX	MEDP
Gross margin	44.38%●	28.76%
Operating margin	17.85%	20.97%●
Net margin	10.73%	17.67%●
ROE	15.78%	113.29%●
ROIC	7.69%	67.94%●

Dividends

Metric	EFX	MEDP
Dividend yield	1.23%	—
Payout ratio	39.55%	—

Growth (annualized)

Metric	EFX	MEDP
Revenue CAGR (5Y)	6.82%	22.03%●
EPS CAGR (5Y)	4.60%	30.90%●
FCF CAGR (5Y)	8.02%	24.42%●
Total return CAGR (5Y)	-6.66%	26.97%●

Frequently asked

Which is better, EFX or MEDP?: It depends on your goal. value: EFX (lower P/E); growth: MEDP (faster 5Y revenue CAGR); quality: MEDP (higher ROIC). Across all compared metrics, MEDP leads 9 to 7.
Is EFX or MEDP cheaper?: On trailing earnings, EFX is cheaper: EFX trades at a 24.97 P/E and MEDP at 35.23.
Which has grown faster, EFX or MEDP?: Over the past five years, MEDP grew revenue faster — EFX at a 6.82% CAGR versus MEDP at 22.03%.
Does EFX or MEDP pay a bigger dividend?: EFX pays a dividend (1.23% yield) while MEDP does not currently pay one.
Is EFX or MEDP more profitable?: MEDP runs the higher net margin — EFX at 10.73% versus MEDP at 17.67%.
Which has been the better investment, EFX or MEDP?: Over the past 5-year, MEDP delivered the higher annualized total return — EFX at 3.40% versus MEDP at 26.97%. Past performance doesn't predict future results.

Go deeper

Full EFX analysis Full MEDP analysis Interactive comparison tool

Dig into the metrics

Equifax P/E ratio Medpace P/E ratio Equifax dividend yield Medpace dividend yield Equifax ROE Medpace ROE Equifax operating margin Medpace operating margin Equifax revenue growth Medpace revenue growth Equifax free cash flow Medpace free cash flow

Equifax & Medpace appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 24, 2026.